Cero Therapeutics Holdings, Inc.

Biotechnology company · South San Francisco, California, United States · OTC: CERO

Cero Therapeutics Holdings, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on OTC under the ticker CERO. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Cero Therapeutics Holdings at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2021
Stock listingOTC: CERO
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1870404

What does Cero Therapeutics Holdings do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5 million sold (2025).

Frequently asked questions about Cero Therapeutics Holdings

Where is Cero Therapeutics Holdings headquartered?

Cero Therapeutics Holdings, Inc. is headquartered in South San Francisco, California, United States.

What does Cero Therapeutics Holdings do?

Cero Therapeutics Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Cero Therapeutics Holdings a public company?

Yes. Cero Therapeutics Holdings, Inc. trades on OTC under the ticker CERO.

When was Cero Therapeutics Holdings founded?

The earliest incorporation on record for Cero Therapeutics Holdings, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences